Meeting 2
From 2012e.igem.org
Line 11: | Line 11: | ||
|} | |} | ||
<div align="center"> | <div align="center"> | ||
+ | What is the model chosen? In order to select one, we must justify why we chose it. | ||
+ | |||
+ | To assess the justification: | ||
+ | 1. Perform a Delphi Analysis, as well as studies by economists using the experts model to determine which model works for us and weigh the importance of the variables. This can also be done through a multi-criteria analysis. | ||
+ | |||
+ | 2. Conduct a review of case studies and the history of the original model of Broker to certify that this can work applied to synbio. | ||
+ | |||
+ | 3. Define all the features that will characterize our model. | ||
+ | |||
+ | 4. Demonstrate that this model is feasible for our country and analyze it in the context of the Central American Region / Latin America. For this, it is essential to research and have strong references that support our decision. | ||
+ | |||
+ | 5. Place the Economic Indicators (we can also study the cultural and social aspects) of Panama vs. The CA Region. | ||
+ | |||
+ | 6. Investigate economical and financial indicators in the MEF, MICI and Senacyt. For example: positioning of economic growth, industrial growth, R & D, Foreign Direct Investment, Innovation. | ||
+ | |||
+ | 7. Create a program of multi-criteria analysis with all indicators, fed with data from different parts of the world, to study which of the 5 models chosen before can be identified as successful in synbio if other scenarios. It should be able to determine which model works best for a given region, country or economy. | ||
+ | |||
+ | 8. Communicate with UTP and DGTC on linking educational institutions (in our case the UTP) and research centers to make our company, if we have an approach: | ||
+ | a. Pure Business, Independent | ||
+ | b. Spin off / Joinventor For an institution (UTP) or NGOs | ||
+ | |||
+ | 9. Conduct a study of the history of biotechnology as a business. We need to understand how biotechnology companies work and have made money over time so we will study the cases of: | ||
+ | • Amyris | ||
+ | • Oil Sands synbio Project |
Revision as of 21:32, 17 July 2012
Home |
What is the model chosen? In order to select one, we must justify why we chose it. To assess the justification: 1. Perform a Delphi Analysis, as well as studies by economists using the experts model to determine which model works for us and weigh the importance of the variables. This can also be done through a multi-criteria analysis. 2. Conduct a review of case studies and the history of the original model of Broker to certify that this can work applied to synbio. 3. Define all the features that will characterize our model. 4. Demonstrate that this model is feasible for our country and analyze it in the context of the Central American Region / Latin America. For this, it is essential to research and have strong references that support our decision. 5. Place the Economic Indicators (we can also study the cultural and social aspects) of Panama vs. The CA Region. 6. Investigate economical and financial indicators in the MEF, MICI and Senacyt. For example: positioning of economic growth, industrial growth, R & D, Foreign Direct Investment, Innovation. 7. Create a program of multi-criteria analysis with all indicators, fed with data from different parts of the world, to study which of the 5 models chosen before can be identified as successful in synbio if other scenarios. It should be able to determine which model works best for a given region, country or economy. 8. Communicate with UTP and DGTC on linking educational institutions (in our case the UTP) and research centers to make our company, if we have an approach: a. Pure Business, Independent b. Spin off / Joinventor For an institution (UTP) or NGOs 9. Conduct a study of the history of biotechnology as a business. We need to understand how biotechnology companies work and have made money over time so we will study the cases of: • Amyris • Oil Sands synbio Project |